Prof. Dr. Mathieu Groussin Principle Investigator Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) m.groussin@ikmb.uni-kiel.de P2 (Phase 2)
Prof. Dr. Mathilde Poyet Principle Investigator Institute for Experimental Medicine (IEM) / Kiel University (CAU) m.poyet@iem.uni-kiel.de P2 (Phase 2)
Prof. Dr. med. Jan Rupp Principle Investigator Department of Infectious Diseases and Microbiology (KIM) / Lübeck University (UzL), University Medical Center Schleswig-Holstein (UKSH) Jan.Rupp@uksh.de P8 (Phase 1)
Prof. Dr. med. Philip Rosenstiel Principle Investigator, Platform leader Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU), University Medical Center Schleswig-Holstein (UKSH) p.rosenstiel@mucosa.de P3 (Phase 1),P3 (Phase 2)
Prof. Dr. med. Susanne Krauss-Etschmann Principle Investigator Kiel University (CAU), Research Center Borstel, Leibniz Lung Center skrauss-etschmann@fz-borstel.de P4 (Phase 1)
Dr. rer. nat. Silke Heinzmann Principle Investigator Research Unit Analytical BioGeoChemistry / Helmholtz Zentrum München silke.heinzmann@helmholtz-munich.de Z (Phase 1),Z (Phase 2)
